standard-title
Alzheimer’s Disease
Latest News Regarding Alzheimer’s Disease and Your Health
Loading…
Ketogenic, or keto, diets are low-carb and fat-rich, and many people who follow such regimens do it to shed excess weight. However, a keto diet may bring other benefits, too. In particular, it may help keep the brain healthy and young, as new research in mice seems to suggest. Can a keto diet protect brain health, and if so, how? A keto diet is high in fat, low in carbohydrates, and has an adequate amount of protein. This kind of diet is meant to trigger ketosis, which is a metabolic process through which the body breaks down fat and protein and transforms them into energy, leading to weight loss. Besides triggering weight loss, a keto diet may also bring other health benefits, as studies have recently suggested. For instance, one such study argued that keto diets could help reduce the side effects of certain cancer therapies. Now, researchers from the Sanders-Brown Center on Aging at the University of Kentucky in Lexington, KY, are assessing evidence suggesting that keto diets may also help stave off cognitive decline. The scientists conducted two studies, both in mice. The findings indicate that keto-type diets can protect neurovascular function, as well as metabolic function, in […]
Building on decades of research, a new paper brings us one step closer to a vaccine that targets the neurological hallmarks of Alzheimer’s disease. Prevention may soon be possible. Scientists inch closer to finding a way to prevent Alzheimer’s disease. Alzheimer’s disease, the most common form of dementia, is a degenerative neurological disease. Memory issues are often the first sign of the condition, which steadily progresses over time. Alzheimer’s disease is a growing concern as it appears almost exclusively in older adults. As the number of older people rises in the United States, the number of cases will also increase. Although scientists are still investigating the exact causes of Alzheimer’s disease, they believe that certain neurological markers play a significant role. The disease seems to involve a buildup of specific proteins in the brain called beta-amyloid and tau. Doctors refer to these abnormal congregations as plaques and neurofibrillary tangles respectively. The hunt for a vaccine Current treatments for Alzheimer’s do not stop disease progression, so the search for effective alternatives is ongoing. Some researchers hope that targeting amyloid buildup might make it possible to stop Alzheimer’s in its tracks. Many scientists are on the hunt for a vaccine, including Dr. […]
New research finds that an HIV enzyme plays a crucial role in driving Alzheimer’s-related brain pathology by altering the APP gene. The findings warrant “immediate clinical evaluation of HIV antiretroviral therapies in people with Alzheimer’s disease,” say the authors of the study. The revelations of a recent study suggest that HIV drugs might successfully treat Alzheimer’s disease. Deemed “the most under-recognized public health crisis of the 21st century,” Alzheimer’s disease is the 6th leading cause of death in the United States and has no known cure. Currently, 5.7 million people ln the U.S. are living with the condition, and the Centers for Disease Control and Prevention (CDC) predict that the burden of the disease will double by 2060. Alzheimer’s also puts a significant strain on the American healthcare system. According to recent estimates, Alzheimer’s and other forms of dementia cost the U.S. $226 billion in 2015, and loved ones spend billions of unpaid hours caring for people with the condition. About 40 percent of these caregivers develop depression. The medical community is hard at work trying to understand how this debilitating disorder occurs and what can be done to stop it. For instance, one of the clues that researchers have […]
Regular exposure to stress can impact our physical and mental health, but how does it actually affect our brains? One new Harvard Medical School study answers that question. According to new research, high levels of stress hormones can impact how well the brain functions. Stress — especially when we experience it on a regular basis — takes a significant toll on our minds and bodies. It can make us feel more irritable and constantly tired, and it impacts our ability to focus. Chronic stress can also interfere with our sleep patterns, appetite, and libido, and it can also exacerbate a range of health conditions. These include diabetes, heart disease, and gastrointestinal problems. One study that Medical News Today covered earlier this year, in fact, saw that even minor levels of distress can increase a person’s risk of chronic disease. What impact does stress have on the brain in physiological and cognitive terms? Researchers from Harvard Medical School in Boston, MA, have explored this question and reported their answer in the journal Neurology. The stress hormone affects memory In their study, the researchers worked with participants with an average age of 49 and no diagnosis of dementia. At baseline, the investigators […]
New evidence suggests that atrial fibrillation, in which the heart has an irregular beat, is linked to an increased risk of dementia. This knowledge, however, also indicates a potential preventive strategy, researchers show. An irregular heartbeat speeds up the rate at which cognitive function deteriorates, but there may be an easy way to address this. In a new study paper published yesterday in the journal Neurology, researchers at the Karolinska Institute and Stockholm University, which are in Sweden, explain that atrial fibrillation (A-fib) is linked with an increased risk of developing dementia. In A-fib, the heart’s atria — or the chambers that receive blood and then send it to the ventricles, which pump it out to the rest of the body — beat irregularly. Because of this, blood can pool inside the heart and form clots, which may later circulate to the brain, leading to a stroke. The new study has found that A-fib also increases the risk of another health problem as people age — namely, dementia. However, this warning also comes with an encouraging solution, the authors explain. “Compromised blood flow caused by atrial fibrillation may affect the brain in a number of ways,” as study co-author Chengxuan […]
Recent research into older adults confirms that loneliness is tied to a raised risk of developing dementia. The study also reveals that the effect ranges across a diversity of people and is independent of how much social contact they have. A large new study confirms that loneliness is a risk factor for dementia. Scientists from Florida State University (FSU) in Tallahassee used data on 12,030 individuals from the Health and Retirement Study, a United States government-sponsored longitudinal survey of a nationally representative sample of people aged 50 and older. They report their findings in a paper that now features in The Journals of Gerontology: Series B. “We are not the first people,” says first study author Dr. Angelina Sutin, who is an associate professor in FSU’s College of Medicine, “to show that loneliness is associated with increased risk of dementia.” “But this is by far the largest sample yet, with a long follow-up,” she adds. “And the population was more diverse.” The study data contained measures of loneliness and social isolation and a range of risk factors, including behavioral, clinical, and genetic. Through telephone interviews, individuals had also completed assessments of cognitive ability, a low score on which indicates dementia. […]
Two new studies now suggest that a noninvasive eye scan could soon be used to catch Alzheimer’s disease early. A simple eye scan may soon detect Alzheimer’s in a matter of seconds. The world’s population is aging rapidly and the prevalence of Alzheimer’s disease is on the rise. For this reason, the need for efficient dementia screening methods that can be applied to millions of people is dire. Current diagnostic practices are either invasive or ineffective. For instance, brain scans are costly, and spinal taps — or lumbar punctures — are invasive and potentially harmful. Specialists currently diagnose Alzheimer’s disease using memory tests and by tracking behavioral changes. However, by the time that the symptoms appear, the disease has already progressed. For these reasons, researchers are hard at work trying to devise newer and better diagnostic tools for Alzheimer’s. For instance, some scientists are trying to use a “sniff test” as a way of assessing whether someone has dementia. Now, researchers at Duke University in Durham, NC, say that Alzheimer’s could be diagnosed in seconds just by looking at a person’s eyes, and scientists at the Sheba Medical Center in Israel concur. Two new studies presented at AAO 2018 — […]
An artificial intelligence tool taught to analyze brain scans can accurately predict Alzheimer’s disease several years before a final diagnosis. Researchers used PET scans to train a deep learning algorithm to predict signs of Alzheimer’s. The team responsible suggests that, after further validation, the tool could greatly assist the early detection of Alzheimer’s, giving treatments time to slow the disease more effectively. The researchers, from the University of California in San Francisco, used positron-emission tomography (PET) images of 1,002 people’s brains to train the deep learning algorithm. They used 90 percent of the images to teach the algorithm how to spot features of Alzheimer’s disease and the remaining 10 percent to verify its performance. They then tested the algorithm on PET images of the brains of another 40 people. From these, the algorithm accurately predicted which individuals would receive a final diagnosis of Alzheimer’s. On average, the diagnosis came more than 6 years after the scans. In a paper on the findings, which the Radiology journal has recently published, the team describes how the algorithm “achieved 82 percent specificity at 100 percent sensitivity, an average of 75.8 months prior to the final diagnosis.” “We were very pleased,” says co-author Dr. […]
For the first time, researchers have identified two clusters of genes that appear to generate the neurological hallmarks of dementia. The discovery provides a new path toward drug discovery. Understanding the genetic mechanisms behind Alzheimer’s moves us ever closer to an effective treatment. Dementia is a growing concern throughout the Western world and beyond. According to the Alzheimer’s Association, around 5.7 million adults in the United States are living with Alzheimer’s, the most common form of dementia. By 2050, that figure is expected to rise to about 14 million. As the average lifespan extends, so does the reach of dementia. Currently, there is no cure for dementia and no way to slow its progress. Although many questions about dementia remain unanswered, our understanding is steadily growing. For instance, we know that a protein called tau plays an important role in a number of dementia types. Tau and dementia In healthy nerve cells, tau helps stabilize microtubules — the scaffolding that helps maintain the structure and rigidity of cells. In dementia, however, tau becomes hyperphosphorylated and clumps together in so-called neurofibrillary tangles. Scientists think that when tau is tangled, it damages nerve cells in at least two ways. Firstly, it can […]
Millions of people worldwide live with a form of dementia, the most common of which is Alzheimer’s disease. Currently, there is no way to halt its progress, but clinical trials of new drugs are underway. What approach will serve specialists best? A new review of clinical trials advises on the best way forward. According to the World Health Organization (WHO), approximately 50 million people around the world live with dementia, and approximately 60–70 percent have Alzheimer’s disease. The greatest risk factor for Alzheimer’s disease is aging, and people ages 65 or older are the most vulnerable. Current treatments for this condition address its symptoms, such as memory loss and behavioral changes. However, more and more research aims to find a therapy that will tackle the biological changes that characterize Alzheimer’s disease. But are researchers on the right track with their investigations, and what would be the best treatment approach? A new comprehensive review published in the journal Neurology, and available online, addresses these questions. Most trials target brain pathologies In the review, specialists from the Alzheimer’s Drug Discovery Foundation in New York, NY analyze current clinical trials for dementia drugs and advise about the best approach going forward. “Alzheimer’s is […]
Dementia refers to a series of neurodegenerative diseases, such as Alzheimer’s, where a person’s memory and other cognitive abilities decline. A recent study may have found a new risk factor that might predispose people to dementia: lung disease. To limit the risk of dementia, people may also want to look after the health of their lungs, a new study suggests. According to the study by researchers from the University of Minnesota’s School of Public Health in Minneapolis in collaboration with colleagues from other academic institutions in the United States, people who experience lung disease in midlife may have an increased risk of dementia later on. The study’s findings appear in the American Journal of Respiratory and Critical Care Medicine, a journal of the American Thoracic Society. The research indicates associations between both restrictive and obstructive lung diseases and dementia or cognitive impairment risk. Doctors use the term restrictive lung diseases when the lungs are unable to expand. Such diseases include idiopathic pulmonary fibrosis, in which the lungs present scarring, and sarcoidosis, where some lung tissue becomes abnormally swollen. In obstructive lung diseases, something obstructs the air flow in or out of the lungs. The most common type of obstructive lung […]
The largest genetic study of Alzheimer’s disease to date finds that a “handful of gene variants” increases some people’s risk of both dementia and cardiovascular disease. The findings imply that, in principle, we may be able to repurpose some cardiovascular drugs to prevent or treat Alzheimer’s. The findings of a new study raise the question: could drugs for cardiovascular problems prevent Alzheimer’s? Alzheimer’s disease already affects a large number of older adults in the United States and worldwide, but the Centers for Disease Control and Prevention (CDC) warn that the burden of the condition will double in the U.S. by 2060. Currently, about 5.7 million Americans are living with the condition, and experts expect this number to reach almost 14 million in the next four decades. As a result, both tracking down the root cause of Alzheimer’s and moving closer to a cure are of critical importance. Researchers know that this neurodegenerative condition has a strong genetic component. For instance, a person with one copy of the APOE4 gene variant is twice as likely to develop Alzheimer’s as someone without it, while having two copies may increase the risk up to 12-fold. The APOE gene encodes a protein called apolipoprotein […]
Parkinson’s disease is a neurological condition with a wide range of effects, including problems with movement, blood pressure and thinking, and mood, sensory, and sleep difficulties. The symptoms of Parkinson’s disease (PD) usually begin gradually, and they affect each person differently. The symptoms a person has will vary widely, regardless of how severe they are or how quickly they develop. Read on to find out more about the different types of symptoms and how to recognize the early symptoms of PD. Early symptoms Around 7 out of 10 people with PD experience tremor at some stage. The symptoms of PD affect individuals differently, but some can be an early sign of the disease. These are: REM sleep disorder and other sleep problems the loss of the sense of smell tremor, especially in one hand a smaller size of handwriting difficulty moving or walking or a stooping gait constipation loss of facial expression, that may make the person look emotionless a low or soft voice Primary motor symptoms The four main signs and symptoms include: slow physical movements, known as bradykinesia shaking, or tremor muscle stiffness, or rigidity problems with balance and coordination, known as postural instability Symptoms often start on […]
Previous research suggested that hearing loss and abnormalities in the eye are tied to memory loss and a higher Alzheimer’s risk. New evidence now indicates that addressing hearing and sight problems can slow down cognitive decline. Opting for hearing aids and cataract surgery can make a big difference when it comes to slowing down cognitive decline. Existing studies have pointed out that there is a link between the quality of a person’s hearing and their eye health and their exposure to cognitive decline. For instance, one such study covered on Medical News Today suggested that poor hearing may correlate with a poor memory. Another one proposed that we could detect Alzheimer’s disease by looking for tell-tale abnormalities in a person’s eyes. Now, two new papers — each based on studies conducted by the same scientists from the University of Manchester in the United Kingdom — look at the evidence indicating that treating hearing loss and eyesight problems can slow down the development of cognitive decline. One of the papers, published in the journal PLOS One, shows that people who have had surgery for cataract — which is condition that can lead to vision loss in the absence of a surgical […]
Doctors may find it hard to diagnose Alzheimer’s disease before the obvious symptoms set in, and many of the current tests for it are expensive and complicated. However, researchers recently devised a blood test that could accurately detect this condition. Recent research aimed to develop an accurate blood test to diagnose Alzheimer’s. According to the Alzheimer’s Association, the condition will affect an estimated 5.7 million people in the United States by 2050. Despite this, there are few ways of accurately diagnosing Alzheimer’s disease early on. These include MRI and CT scans, which help doctors rule out other conditions that might cause similar symptoms. Another way of diagnosing Alzheimer’s is by collecting cerebrospinal fluid and looking for biomarkers of the disease. This is the most accurate test for this neurodegenerative condition, but it is costly and invasive. For all these reasons, researchers from Brigham and Women’s Hospital in Boston, MA, have been developing a blood test for Alzheimer’s that aims to be accurate, more cost-effective, and less unpleasant. In the study paper, which appears in the journal Alzheimer’s & Dementia, the researchers explain that the test may be able to detect biomarkers of Alzheimer’s disease before the appearance of obvious symptoms. […]
By the time that the symptoms of dementia emerge in Alzheimer’s disease, tissue damage is well underway in the brain. Now, scientists propose that specific psychiatric symptoms – such as depression, anxiety, sleep disruption, and loss of appetite – may serve as markers of very early brain changes in Alzheimer’s. Depression and anxiety may be signs of early-stage Alzheimer’s. Working with the Brazilian Biobank for Aging Studies (BBAS) at the University of São Paulo, investigators at the University of California in San Francisco (UCSF) studied results of postmortem brain tissue tests and compared them with psychiatric symptoms obtained from detailed interviews conducted with people who knew the deceased well, such as relatives and carers. They suggest that their study — a paper on which now features in the Journal of Alzheimer’s Disease — reveals that psychiatric symptoms are not the cause of Alzheimer’s, but more likely early indicators of the disease. Such markers could help doctors to diagnose Alzheimer’s disease much earlier and thus increase opportunities for slowing its progress, they note. Better understanding of Alzheimer’s The authors also propose that the findings could alter our understanding of how the biology of Alzheimer’s leads to psychiatric symptoms in people who […]
A protein that plays a key role in early neural development is also essential for learning and memory in the adult brain. A protein called netrin may boost learning and memory by strengthening neural connections in the adult brain. The protein, called netrin, strengthens connections between brain cells. This is according to recent research led by the Montreal Neurological Institute and Hospital (The Neuro), a teaching and research institute of McGill University in Canada. Scientists already knew that netrin is essential for the development of the embryonic and infant brain, where it helps make connections between brain cells, or neurons. The recent research reveals that the protein also strengthens those neural connections, or synapses, in the adult brain’s hippocampus, an area that is involved in memory and learning. The journal Cell Reports recently published a paper on the study, which the team conducted on cells from developing and adult rat brains. “It was a mystery,” comments senior study author Dr. Timothy E. Kennedy, who runs a research laboratory at The Neuro, “why neurons would continue making netrin in the adult brain after all the connections had already been made in infancy.” Molecule key for synapse strengthening According to Dr. Kennedy, […]
Recent research has found that short daily practice of mind-body therapy may help alleviate some of the signs and symptoms that often precede dementia. Practicing an easy type of meditation daily may relieve some dementia symptoms. The researchers behind the new study assessed a group of older adults experiencing memory difficulties who practiced 12 minutes per day of music listening or simple yoga meditation for 12 weeks. Samples of their blood from before and after the 3 months of therapy revealed changes in levels of certain markers with associations to cell aging and Alzheimer’s disease. These changes also linked directly to improvements in subjective assessments of cognitive function, mood, sleep, and quality of life. Dr. Kim Innes, a professor at West Virginia University School of Public Health in Morgantown, led the study and is first author of the study paper, which features in the Journal of Alzheimer’s Disease. Blood markers as predictors of Alzheimer’s The team chose to measure a number of blood markers that “have emerged as possible predictors of cognitive decline and dementia.” These included telomere length, telomerase activity, and levels of certain beta-amyloid peptides with links to Alzheimer’s disease. Telomeres are “protective caps” that work to prevent […]
Men who follow a healthful diet could be protecting their brains, according to a new study that tracked a large group of men for more than 2 decades. Leafy greens and red and orange vegetables correlated with reduced memory loss in a new study. Researchers from the Harvard T.H. Chan School of Public Health in Boston, MA, analyzed data from a study that had followed 27,842 men for 26 years. The men had all filled in detailed surveys about their food and drink intake at the start of the study in 1986 — when they were aged 51 years, on average — and then every 4 years until 2002. The follow-up lasted until 2012, by which time their average age was in the mid- to late-70s. During the last few years of the follow-up, they had also completed short tests to find out whether they had noticed any decline in their own ability to think and remember things. The analysis showed that consuming higher amounts of certain foods and drinks was tied to lower risk of decline in memory and thinking skills. The foods that most strongly showed this effect were leafy greens, red and dark orange vegetables, berry fruits, […]
A new study finds that people with Alzheimer’s disease who also took antidiabetes medication exhibited fewer molecular markers of the neurological condition. These findings could inform future Alzheimer’s treatments. A study examined the molecular pathways of brain tissue and the cells that line the inside of blood vessels in the brains of people with Alzheimer’s and diabetes. New research — led by Vahram Haroutunian, Ph.D., a professor of psychiatry and neuroscience at the Icahn School of Medicine at Mount Sinai in New York City, NY — analyzed the brain tissues of people who had both Alzheimer’s disease and diabetes. The findings suggest that antidiabetes drugs may protect the brain against Alzheimer’s. As Prof. Haroutunian and colleagues explain in their paper, a mounting body of evidence has been pointing to a link between the risk of mild cognitive impairment, dementia, and type 2 diabetes. Additional studies have uncovered an association between an insulin receptor pathway in the brain and the accumulation of Alzheimer’s-specific brain pathologies. Previous studies conducted by the same Prof. Haroutunian and colleagues found that the brains of people with Alzheimer’s who had also undergone treatment for diabetes, such as insulin or antidiabetes medicine, had reduced brain pathologies. So, […]
Dementia and Alzheimer’s disease are similar but not the same. Dementia is a general term and has many different types, of which Alzheimer’s is one. There is sometimes confusion between the two because people often use the terms interchangeably. Dementia is an umbrella term used to describe a set of symptoms that broadly affect cognitive functioning, including: memory thinking and focus problem solving language visual perception Alzheimer’s disease is a specific type of dementia that causes a gradual decline in memory and thinking. What is dementia? Some dementia symptoms can be mild and difficult to detect. Dementia is a syndrome, which means that it describes a collection of symptoms with no specific cause. A syndrome is different from a disease, which has specific symptoms and a common cause. Dementia can affect a wide range of mental functions. As a result, many different diseases and conditions are types of dementia. Alzheimer’s disease is the most common form of dementia, but there are several other types, including: vascular dementia, which results from strokes or other conditions that block blood flow to the brain Lewy body dementia, which is a result of abnormal protein deposits in the brain frontotemporal disorders, which are types […]
Scientists have now proved that drinking certain types of coffee can be beneficial to brain health, but how does this popular brew support cognitive function? A new study identifies some of the mechanisms that allow coffee to keep mental decline at bay. What makes coffee an ally of brain health? According to data from the Harvard T.H. Chan School of Public Health in Boston, MA, about 54 percent of all adults in the United States drink coffee on a daily basis. While drinking coffee can bring both benefits and risks for a person’s health, a 2016 study from the University of Ulster in Coleraine, United Kingdom, concluded that the health benefits of moderate coffee consumption “clearly outweigh” the potential risks. One of these benefits is that coffee seems to protect the brain against cognitive impairments and boost thinking skills. How does this happen, and what is it about coffee that is so beneficial to cognitive health? These are some questions that a new study from the Krembil Brain Institute — part of the Krembil Research Institute in Toronto, Canada — aims to answer. “Coffee consumption does seem to have some correlation to a decreased risk of developing Alzheimer’s disease and […]
A recent article raises important questions about the prevalence of firearms in the aging population of the United States. The authors argue that there is a vital need to discuss the relationship between dementia and guns. A recent article investigates the issue of gun ownership in an aging population. Gun ownership is a controversial topic, and people are sure to continue debating it for many years to come. This debate often focuses on young men and violent crime, but a recent article investigates the other end of the age spectrum. Older adults are more likely to own a gun than younger people. An estimated 27 percent of people over the age of 65 years own at least one gun, while 37 percent live in a home where a firearm is present. A seemingly unrelated but equally hot topic is the rise of dementia. Dementia and firearms As dementia occurs almost exclusively later in life, the longer that people live, the more prevalent it becomes. Currently, around 5.7 million people in the U.S. are living with Alzheimer’s disease. Although Alzheimer’s is the most common form of dementia, it only accounts for 60–80 percent of all dementia cases. A recent article in […]
According to a team of Swedish-based researchers, breathing through the nose may help memory storage and consolidation. These findings are published in The Journal of Neuroscience. The way we breathe affects our memory in mysterious ways. Recently, neuroscientists have been scrutinizing the link between smell and memory. Some have suggested that a damaged sense of smell can predict dementia, and others have zoomed in on why that may be. Along the way to unraveling the Proustian mysteries of smells and memory, scientists have picked up several clues. The amygdala, which is a small brain region that processes sensory information, is close to the memory-storing hippocampus. Also, newer research shows that people with a good spatial memory may be better at identifying smells. Information related to time and space is present in the anterior olfactory nucleus, studies have shown. This is a brain area that is involved in the development of Alzheimer’s. New research now adds breathing into the mix. A study carried out by scientists at the Karolinska Institutet in Stockholm, Sweden, finds that breathing through the nose, rather than the mouth, improves olfactory memory. Artin Arshamian, a researcher at the Department of Clinical Neuroscience with the Karolinska Institutet, is […]
People with a diagnosis of dementia can also face depression. For this reason, they may end up taking antidepressant drugs. Now, a study has found that these drugs may be able to treat not just depression, but dementia itself. A new study tests out the potential of antidepressants to tackle dementia mechanisms in the brain. According to data cited by the Alzheimer’s Association, 1 in 10 people aged 65 and over has Alzheimer’s disease, a form of dementia, characterized chiefly by memory loss, disorientation, and having trouble with normal daily activities. Moreover, people with Alzheimer’s can often also develop mental health issues, especially depression. For this reason, healthcare professionals may prescribe selective serotonin reuptake inhibitors (SSRIs) — a class of antidepressants — to individuals with dementia. Recently, researchers from the University of Waterloo in Ontario, Canada, have found a surprising mechanism at play, namely that SSRIs appear to inhibit the growth of dementia-specific aggregates in the brain. “These are promising findings for people with Alzheimer’s who are on SSRIs,” notes Prof. Praveen Nekkar Rao, one of the current study’s authors. “These finding may not only highlight benefits for people with depression and Alzheimer’s but can also provide insights to serve […]
Blocking an enzyme could put a stop to the buildup of toxic protein clumps that occurs in the brains of people with Parkinson’s disease. New research reveals that blocking a certain protein clears Lewy bodies — toxic structures that are a hallmark of Parkinson’s disease. This was the conclusion that scientists at Georgetown University Medical Center (GUMC) in Washington, D.C. reached after studying the enzyme, called USP13, in the brains of mice and humans. The study, which features in the journal Human Molecular Genetics, may be the first to explain USP13’s role in the toxic accumulation of protein clumps in the brain. The protein accumulations are called Lewy bodies, and they also occur in other neurodegenerative diseases, including Lewy body dementia and multiple system atrophy. “This study,” says lead author Xiaoguang Liu, an assistant professor of neurology at GUMC, “provides novel evidence that USP13 affects development and clearance of Lewy body protein clumps, suggesting that targeting USP13 may be a therapeutic target in Parkinson’s disease and other similar forms of neurodegeneration.” Parkinson’s disease and Lewy bodies Parkinson’s disease is a degenerative disorder that chiefly affects movement control. Typical symptoms include tremors, stiffness, and bradykinesia, which is a slowness of movement. […]
The herpes virus could account for at least half of Alzheimer’s cases, according to a new review of the findings of three recent studies examining links between Alzheimer’s and herpes. Infection with the herpes simplex virus may boost the likelihood of developing Alzheimer’s, researchers suggest. The new paper, published in the Frontiers in Ageing Neuroscience journal, also suggests that antiviral drugs may reduce the risk of senile dementia — which is mostly caused by Alzheimer’s disease — among people who have severe cases of herpes. Herpes simplex virus 1 (HSV1) is the type of herpes that results in cold sores. HSV1 is a common virus, and the majority of people will have contracted it by the time they reach old age. However, the virus remains permanently in the body and cannot be decisively removed either by the body’s natural defense mechanisms or by drugs. The virus is inactive most of the time, but when a person has HSV1, they may find that flare-ups occur when they are stressed or sick, resulting in characteristic blisters. Medical News Today have reported on several studies this year alone that have provided evidence of a connection between Alzheimer’s and herpes. In June, we looked […]
close
The information contained within this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Members contribute personal experiences by sharing what did or didn’t work to address their concern and help educate others which may expedite recovery. As such, always seek the advice of your physician or other qualified health provider with any questions about your medical condition. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
Recent Comments